HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $256 | -25.6% | 6,695 | +10.8% | 1.28% | +6.3% |
| Q4 2022 | $344 | -99.8% | 6,042 | +14.9% | 1.20% | +51.9% |
| Q3 2022 | $208,000 | -31.4% | 5,257 | -23.6% | 0.79% | -11.0% |
| Q2 2022 | $303,000 | +21.2% | 6,877 | +9.7% | 0.89% | +55.1% |
| Q1 2022 | $250,000 | -8.1% | 6,267 | -7.3% | 0.57% | +32.0% |
| Q4 2021 | $272,000 | -27.7% | 6,761 | -26.9% | 0.44% | -4.4% |
| Q3 2021 | $376,000 | -11.5% | 9,254 | -1.0% | 0.46% | -8.6% |
| Q2 2021 | $425,000 | -1.6% | 9,350 | -9.7% | 0.50% | +4.6% |
| Q1 2021 | $432,000 | +104.7% | 10,359 | -23.3% | 0.48% | +106.1% |
| Q3 2019 | $211,000 | – | 13,500 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |